Impact X Capital Partners
VC Fund
London, United Kingdom
Impact X Capital Partners is a VC fund in London focused on FinTech and Software. We are a double bottom line venture capital firm founded to support underrepresented entrepreneurs across Europe.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries Impact X Capital Partners invests in
Stages Impact X Capital Partners invests in
Countries Impact X Capital Partners invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Didier Lambert
|
|||
Eric Collins
|
|||
Ijeoma Okoli
|
|||
Joe Voyticky
|
Investment Focus
Industry
- FinTech 2 (33%)
- Software 2 (33%)
- Health Care 2 (33%)
- Medical 1 (17%)
- E-Commerce 1 (17%)
Stage
- Seed 4 (67%)
- Pre-Seed 1 (17%)
- Series A 1 (17%)
Country
- United States 3 (50%)
- United Kingdom 2 (33%)
- Sweden 1 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Ursula Burns
Founding Members
|
Founding Members | Total investments: 5 | Find email | |
|
Didier Lambert
Founding Members
|
Founding Members | Total investments: 0 | Find email | |
|
Eric Collins
General Partner, CEO and Founding Member
|
General Partner, CEO and Founding Member | Total investments: 1 | Find email | |
|
Ijeoma Okoli
Founding Member
|
Founding Member | Total investments: 0 | Find email | |
|
Joe Voyticky
Founding Members
|
Founding Members | Total investments: 0 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Salvo Health
|
Salvo is emerging as the leader in helping GI providers leap into a hybrid-care vision of the future of medicine, providing brick & mortar clinics with an easy to implement continuous care platform that saves time, increases revenue and improves patient outcomes.The company has announced agreements with 771 GI’s, representing 15% of allindependent GI’s in the US, to deploy wraparound care for their clinic patients. Included in its customers are five of the largest GI practices in the country, together seeing over 1.1 million GI patients a year. Salvo provides the tech and care delivery for modern, interdisciplinary care to treat chronic conditions that have surged in cost and prevalence: --IBS and IBD (over 40M affected) -- GERD and Celiac (over 50M affected) --MASH/MASLD, what was previously called “fatty liver disease” (over 80M) --Obesity (over 100M) The care benefits patients (76% of patients reported improved symptoms, five accepted medical conference abstracts on outcomes), generates incremental profit for practices (over $2M EBITDA improvement for a 100 GI practice), and reduces total healthcare costs (79% drop in GI-related ER utilization). | $8.5M / Series A / Jan 22, 2026 | |
Cetasol
|
Cetasol is an innovative technology firm focusing on intelligent solutions for sustainability in marine sector. It helps in decision-making, timesaving, emission reduction, and more. They provide solutions to enhance maritime operations and services for consultant improvements. | $2.1M / Seed / Apr 29, 2024 | |
Bump
|
Bump is an AI-powered analytics-driven platform that helps creators receive and manage microadvances for their businesses. It also helps in tracking and collecting lost revenue, determining qualification for micro-financing, and booking personalized live sessions directly with entertainment industry executives to let creators eliminate traditionalbarriers faced while receiving requisite resources. | $3M / Seed / Apr 23, 2024 | |
Afrocenchix
|
Afro haircare is a $42B market and it’s growing fast. But the big players don’t understand the customers or their problems. We’ve had those problems, and our customer centric, data driven approach at Afrocenchix has helped us to formulate, manufacture & sell over 65,000 bottles of our safe, effective products so far. Our award-winningproducts and featured in top publications such as Vogue, and on the Indy Best lists and have an average 4.7 star review from 1000s of customers. We’re just getting started. | $1.2M / Seed / Jul 08, 2021 | |
Research Grid (R.grid)
|
R.grid has built machine learning-based software for medical research. | $1.6M / Seed / Mar 09, 2020 | |
Business Score
|
Funding marketplace for eCommerce companies | $1.9M / Pre-Seed / Aug 22, 2019 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Impact X Capital Partners invest in?
Impact X Capital Partners invests primarily in FinTech, Software and Health Care startups, most often at Seed and Pre-Seed stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Impact X Capital Partners?
Public channels for Impact X Capital Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Impact X Capital Partners?
The team at Impact X Capital Partners includes Ursula Burns (Founding Members), Didier Lambert (Founding Members) and Eric Collins (General Partner, CEO and Founding Member), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
